US Broker Ratings

Johnson & Johnson (JNJ) Stock Analysis: A Healthcare Giant with a Promising 1.79% Potential Upside

Johnson & Johnson (NYSE: JNJ), a stalwart in the healthcare sector, continues to capture investor interest, combining a robust market presence with steady growth potential. With a towering market capitalization..

Biogen Inc. (BIIB) Stock Analysis: A Closer Look at Its 11.98% Potential Upside

Biogen Inc. (BIIB), a prominent player in the healthcare sector, particularly within the drug manufacturing industry, has drawn investor interest with its expansive portfolio of therapies targeting neurological and neurodegenerative..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Exploring a 9.34% Potential Upside in the Healthcare Sector

Smith & Nephew SNATS, Inc. (NYSE: SNN), a stalwart in the medical devices industry, presents an intriguing opportunity for investors seeking exposure to the healthcare sector. The London-based company, with..

Merck & Co. (MRK) Stock Analysis: Exploring Growth Potential and Strong Analyst Sentiment

Merck & Company, Inc. (NYSE: MRK), a global leader in the healthcare sector, continues to capture investor attention thanks to its robust pipeline, strategic partnerships, and favorable analyst ratings. With..

Insulet Corporation (PODD) Stock Analysis: 37.68% Potential Upside Amid Strong Revenue Growth

Insulet Corporation (NASDAQ: PODD), a prominent player in the healthcare sector, particularly in medical devices, is making waves with its innovative insulin delivery systems. With a substantial market capitalization of..

Encompass Health Corporation (EHC) Stock Analysis: Exploring a 42% Upside Potential with Robust Analyst Ratings

Encompass Health Corporation (NYSE: EHC) stands out in the healthcare sector with its specialized focus on post-acute healthcare services. Based out of Birmingham, Alabama, Encompass Health operates extensive inpatient rehabilitation..

Illumina, Inc. (ILMN) Stock Analysis: Navigating Valuation Challenges Amidst Growth Opportunities

Illumina, Inc. (NASDAQ: ILMN), a pivotal player in the diagnostics and research industry, continues to command attention from investors due to its cutting-edge genetic and genomic analysis solutions. As a..

Hologic, Inc. (HOLX) Stock Analysis: Exploring Growth Potential Amidst a Healthcare Innovation Drive

Hologic, Inc. (NASDAQ: HOLX), a pivotal player in the healthcare sector, specializes in medical instruments and supplies, primarily focusing on women’s health. With a market capitalization of $16.75 billion, Hologic..

Pfizer, Inc. (PFE) Stock Analysis: Navigating the 6.71% Dividend Yield Amidst Market Volatility

Pfizer Inc. (NYSE: PFE), a titan in the healthcare sector, stands as a beacon of innovation and resilience in the drug manufacturing industry. Headquartered in New York, Pfizer’s operations span..

Baxter International Inc. (BAX) Stock Analysis: Navigating Growth with a 16.60% Potential Upside

Baxter International Inc. (NYSE: BAX) is a prominent player in the healthcare sector, specializing in medical instruments and supplies. With its headquarters in Deerfield, Illinois, and a market capitalization of..

Incyte Corporation (INCY) Stock Analysis: A Biotech Powerhouse with Robust Revenue Growth and Strategic Global Presence

Incyte Corporation (NASDAQ: INCY) stands as a formidable player in the biotechnology sector, boasting a market capitalization of $20.02 billion. This Delaware-based biopharmaceutical company is renowned for its commitment to..

Bristol-Myers Squibb (BMY) Stock Analysis: Evaluating the 4.61% Dividend Yield and Growth Outlook

Bristol-Myers Squibb Company (NYSE: BMY), a stalwart in the global pharmaceutical industry, continues to capture investor interest with its robust dividend yield and strategic growth in biopharmaceuticals. With a market..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Exploring the 15.33% Potential Upside

GE HealthCare Technologies Inc. (NYSE: GEHC), a stalwart in the medical devices sector, is capturing investor attention with its compelling growth prospects and strategic positioning in the healthcare industry. With..

Quest Diagnostics (DGX) Investor Outlook: Navigating a 9.59% Potential Upside in the Healthcare Diagnostics Sector

Quest Diagnostics Incorporated (NYSE: DGX), a leader in the healthcare diagnostics and research industry, is poised to attract investor attention with its potential upside of 9.59%, based on the average..

AbbVie Inc. (ABBV): Investor Outlook and Potential 11.84% Upside with Strong Analyst Support

AbbVie Inc. (NYSE: ABBV), a behemoth in the healthcare sector, continues to capture investor attention with its robust market presence and promising developments in its drug pipeline. With a market..

Agilent Technologies, Inc. (A) Stock Analysis: A Compelling 25.63% Potential Upside Amid Robust Revenue Growth

Agilent Technologies, Inc. (NYSE: A), a leading player in the healthcare sector, particularly in the diagnostics and research industry, offers a significant opportunity for investors with its projected upside potential..

Waters Corporation (WAT) Stock Analysis: Navigating a 4.51% Upside in the Diagnostics & Research Sector

Waters Corporation (NYSE: WAT) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $23.36 billion, this U.S.-based company..

BioNTech SE (BNTX) Stock Analysis: Evaluating the 21.77% Potential Upside Amidst Clinical Innovations

BioNTech SE (NASDAQ: BNTX), a trailblazer in the biotechnology sector, has captured investor attention with its promising pipeline of immunotherapies aimed at treating various forms of cancer and infectious diseases...

Regeneron Pharmaceuticals, Inc. (REGN) Stock Analysis: Navigating a 10.15% Potential Upside Amidst Healthcare Innovation

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) stands out in the biotechnology industry as a formidable player in the healthcare sector. With a market capitalization of $79.87 billion, this U.S.-based company continues..

Labcorp Holdings Inc. (LH) Stock Analysis: Unpacking the 12.52% Potential Upside

Labcorp Holdings Inc. (NYSE: LH), a key player in the healthcare sector, particularly within the Diagnostics & Research industry, has been on investors’ radar due to its solid market presence..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds